[go: up one dir, main page]

CN1058530A - 人工合成矿泉粉 - Google Patents

人工合成矿泉粉 Download PDF

Info

Publication number
CN1058530A
CN1058530A CN 90106701 CN90106701A CN1058530A CN 1058530 A CN1058530 A CN 1058530A CN 90106701 CN90106701 CN 90106701 CN 90106701 A CN90106701 A CN 90106701A CN 1058530 A CN1058530 A CN 1058530A
Authority
CN
China
Prior art keywords
sodium
powder
weight
zinc
potassium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 90106701
Other languages
English (en)
Inventor
高伟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anshan Iron & Steel Co Qianshan Hot Spring Sanatorium
Angang Steel Co Ltd
Original Assignee
Anshan Iron & Steel Co Qianshan Hot Spring Sanatorium
Angang Steel Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anshan Iron & Steel Co Qianshan Hot Spring Sanatorium, Angang Steel Co Ltd filed Critical Anshan Iron & Steel Co Qianshan Hot Spring Sanatorium
Priority to CN 90106701 priority Critical patent/CN1058530A/zh
Publication of CN1058530A publication Critical patent/CN1058530A/zh
Pending legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

一种由钾、钠、锶、锂、锌、溴、碘、硼、硒、硅等盐类 混合组成的人工合成矿泉粉,按1000∶110~170的 比例溶解在热水中即可用于人工矿泉浴。这种矿泉 粉综合了各种天然矿泉水的优点,适用于治疗皮肤搔 痒症、湿疹、外痔、肛裂等疾病,同时也为缺锌者提供 了补充锌的极好的途径。

Description

本发明涉及人工合成矿泉粉。
随着人类社会的发展,对于天然矿泉水对人体的保健作用的认识越来越深。矿泉水中均含有一些对人体有益的成份,可应用于医疗保健。
天然矿泉水因其所处的地理环境不同,所含成份也各不相同,因此其治疗适应症也各不相同,每种天然矿泉水一般仅适应2~3种疾病。
天然矿泉水的使用仅限于矿泉水产地,人们无法将矿泉水送到很远的地方而又不影响其使用价值,因此也在一定程度上限制了天然矿泉水的使用。
为了使人们能在有热水的地方就能洗上矿泉浴,医生和科学家们开始研究人工合成矿泉水,因此出现诸多人工合成矿泉水。例如日本公开特许昭59-130808、昭59-190911,昭61-129112,昭61-145110等都公开了各自的洗浴剂。它们都是模拟天然矿泉水的成份,人工合成的洗浴剂。例如,特开昭59-130808所公开的碳酸型人工洗浴水成份为,1.0Kg浴水中含有0.40gK2CO3,0.20gNa2CO3,0.01gK3PO4,0.01gMgSO4。钠洗浴水成份为,1.0Kg浴水中含有0.40gNa2CO2,0.10gK2CO3,0.02gNa3PO4,0.04gNaCl,0.01gMgSO4,外加香料、着色料若干。特开昭61-145110所公开的洗浴剂成份为含5%的牛黄酸水溶液60重量%,1.3丁二饮用天然矿泉水介限指标及限量指标。
表1:饮用天然矿泉水介限标准和限量指标,mg/l
成份  介限标准  限量标准
Li  >0.2  <5
Sr  >0.2  <5
Br  >1
I  >0.2  <1
B(以H2BO3计) <30
Zn  >0.2  <5
Se  >0.01  <0.05
H2SiO3>25
按照本发明的人工合成矿泉粉,由重量百分比为溴化钾(KBr)2.23~2.67%,氯化锶(SrCl2)3.52~3.79%,碘化钾(KI)0.89~1.17%,碳酸锂(Li2CO3)2.07~2.23%,碳酸氢钠(NaHCO3)33~37.27%,硼酸(H3BO3)7.47~9.3%,亚硒酸钠(Na2SeO3)0.01~0.02%,硅酸钠(Na2SiO3·9H2O)43.28~44.75%,醋酸锌〔(CH3COO)2·Zn·2H2O〕2.6~3.07%,钼酸铵〔(NH46Mo7O24·4H2O〕0.04~0.05%,硫化物(Na2S·9H2O)0~0.6%混合而成。
将110~170mg合成矿泉粉溶解于1立升热水中即成为人工合成矿泉水。醇10重量%,乙醇5重量%,萤光素钠0.8重量%,硝酸0.5重量%,香料4重量%等。
所有这些洗浴剂都起到某种天然矿泉水的作用,但作用有限。
本发明的目的是提供一种能集中各种天然矿泉水的优点,含有多种对人体有益的微量元素,优于某单一类型天然矿泉水,具有防病、健身和治疗某些疾病功能的人工合成矿泉粉。
按照本发明的矿泉粉,其成份是人体必须的,这些元素存在于一切健康的人体机体的组织中,是人体生存和发育不可缺少的物质。
按照本发明的矿泉粉,其主要元素有钾、钠、溴、碘、锌、锶、锂、硒、钼、硅、硼等。将这些元素的易溶盐类按一定比例混合起来,溶解于热水中即形成人工合成矿泉浴。这些盐类在水溶液中全部介离为离子状态,洗浴时离子状态的化学成分透过人体皮肤进入体内,化学物质附在皮肤体表而产生对皮肤的刺激作用,达到治病、防病、健身的目的。
按照本发明,选用作为矿泉粉组份的金属的化学性质必须与某些已知的生理功能相适应,金属氧化态和存在形式没有毒害作用。金属原子外层电子少,易于失去电子而变成带正电的阳离子,从而起到特殊的生理功能及高度的生化效应。
按照本发明的合成矿泉粉中所含的元素能被人体有效地吸收,彼此没有拮抗、抑制吸收作用。人机体对这些元素具有代谢平衡调节机制,对人体无毒害作用。
按照发明所选定的矿泉粉成份附合各国矿泉水成份最低介限标准、
实施例1:
合成矿泉粉的成分为(括号内为每1立升热水中的元素含量mg):
溴化钾(KBr)(Br1.7mg)2.24重量%
氯化锶(SrCl2)(Sr2.2mg)3.58%
碘化钾(KI)(I0.76mg)0.89重量%
碳酸锂(Li2CO3)(Li0.47mg)2.24重量%
碳酸氢钠(NaHCO3)(HCO329mg)35.62重量%
硼酸(H3BO2)(HBO26.4mg)8.04重量%
亚硒酸钠(Na2SeO3)(Se0.01mg)0.01重量%
硅酸钠(Na2SiO3·9H2O)(SiO313mg)44.59重量%
醋酸锌〔(CH3COO)2Zn·2H2O)(Zn0.9)2.67重量%
钼酸铵〔(NH46Mo7O24·2H2O〕(Mo0.02)0.04重量%
合计(约113mg)  100%
本实施例元素含量均在表1所示的限量范围内,将约113mg合成矿泉粉加到1升热水内即成为人工合成矿泉水。
实施例2:
人工合成矿泉粉的成分为(重量百分数):
溴化钾(KBr)(Br2mg)2.31%
氯化锶(SrCl2)(Sr2.5mg)3.52%
碘化钾(KI)(I1.0mg)1.02%
碳酸锂(Li2CO3)(Li0.5mg)2.07%
碳酸氢钠(NaHCO3)(HCO335mg)37.07%
硼酸(H3BO3)(HBO27mg)7.47%
亚硒酸钠(Na2SeO3·5H2O)(Se0.01mg)0.01%
硅酸钠(Na2SiO3·9H2O)(SiO315mg)43.28%
醋酸锌〔(CH3COO)2·Zn·2H2O〕(Zn1mg)2.6%
钼酸铵〔(NH46Mo7O24·2H2O)Mo0.03mg)0.05%
硫化钠(Na2S·9H2O)(S0.1mg)0.6%
合计  100%
将约129mg合成矿泉粉加到1升热水内即成为人工合成矿泉水。
利用上述合成矿泉粉对1400名钢铁和化工工人进行二个月的洗浴观察,对皮肤搔痒症、湿疹、外痔、肛裂等均有明显疗效。浴后人体锌含量明显提高,为缺锌者提供了补充锌的极好途径。

Claims (3)

1、一种由钾、钠、锶、锂、锌、溴、碘等盐类组成的人工合成矿泉粉,其特征在于此种矿泉粉由成份重量百分比为溴化钾(KBr)2.23~2.67%,氯化锶(SrCl2)3.52~3.79%,碘化钾(KI)0.89~1.17%,碳酸锂(Li2CO3)2.07~2.23%,碳酸氢钠(NaHCO3)33~37.27%,硼酸(H3BO3)7.47~9.3%,亚硒酸钠(Na2SeO3)0.01~0.02%,硅酸钠(Na2SiO3·9H2O)43.28~44.75%,醋酸锌[(CH3COO)2Zn·2H2O]2.6~3.07%,钼酸铵[(NH4)6Mo7O24·4H2O]0.04~0.05%,硫化钠0~0.6%所混合而成。
2、一种权利要求1所述的人工合成矿泉粉,其特征在于此种矿泉粉的成份重量百分比约为溴化钾(KBr)2.24%,氯化锶(SrCl2)3.58%,碘化钾(KI)0.089%,碳酸锂(Li2CO3)2.23%,碳酸氢钠(NaHCO3)35.62%,硼酸(H3BO3)8.04%,亚硒酸钠(Na2SeO3)0.01%,硅酸钠(Na2SiO3·9H2O)44.59%,醋酸锌〔(CH3COO)2Zn·2H2O)2.67%,钼酸铵〔(NH46Mo7O24·4H2O〕0.04%。
3、一种权利要求1所述的人工合成矿泉粉,其特征在于此种矿泉粉的成份重量百分比约为:溴化钾(KBr)2.31%,氯化锶(SrCl2)3.52%,碘化钾(KI)1.02%,碳酸锂(Li2CO3)2.07%碳酸氢钠(NaHCO3)37.07,硼酸(H3BO3)7.47%,亚硒酸钠(Na2SeO3)0.01%,硅酸钠(Na2SiO3)43.28%,醋酸锌〔(CH3COO)2Zn·2H2O〕2.6%,钼酸铵〔(NH46·Mo7O24·2H2O〕0.05%,硫化钠(Na2S·9H2O)0.6%。
CN 90106701 1990-08-02 1990-08-02 人工合成矿泉粉 Pending CN1058530A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 90106701 CN1058530A (zh) 1990-08-02 1990-08-02 人工合成矿泉粉

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 90106701 CN1058530A (zh) 1990-08-02 1990-08-02 人工合成矿泉粉

Publications (1)

Publication Number Publication Date
CN1058530A true CN1058530A (zh) 1992-02-12

Family

ID=4880221

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 90106701 Pending CN1058530A (zh) 1990-08-02 1990-08-02 人工合成矿泉粉

Country Status (1)

Country Link
CN (1) CN1058530A (zh)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2732603A1 (fr) * 1995-04-10 1996-10-11 Oreal Utilisation d'un sel de strontium comme antagoniste de substance p
CN1060942C (zh) * 1995-02-23 2001-01-24 邢鹤林 用于治疗再生障碍性贫血的蒙药
CN103479526A (zh) * 2012-06-13 2014-01-01 吴旻 矿泉粉

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1060942C (zh) * 1995-02-23 2001-01-24 邢鹤林 用于治疗再生障碍性贫血的蒙药
FR2732603A1 (fr) * 1995-04-10 1996-10-11 Oreal Utilisation d'un sel de strontium comme antagoniste de substance p
CN103479526A (zh) * 2012-06-13 2014-01-01 吴旻 矿泉粉

Similar Documents

Publication Publication Date Title
Lafferty et al. Tumoral calcinosis: a metabolic disease of obscure etiology
EP1651324A2 (de) Flockungsmittel, verfahren zu dessen herstellung und dessen verwendung
Crisponi et al. Metal ion toxicity
DE3685853T2 (de) Mittel zur behandlung von knochenkrankheiten.
CN106957545A (zh) 一种利用远红外陶瓷粉制得的功能涂料及其制备方法
Featherstone et al. The effect of fluoride, zinc, strontium, magnesium and iron on the crystal-structural disorder in synthetic carbonated apatites
Gomes et al. Health benefits and risks of minerals: bioavailability, bio-essentiality, toxicity, and pathologies
CN1058530A (zh) 人工合成矿泉粉
Rozman et al. Enhanced fecal elimination of stored hexachlorobenzene from rats and rhesus monkeys by hexadecane or mineral oil
Cerklewski Influence of dietary magnesium on fluoride bioavailability in the rat
WO2001038230A1 (en) Water improvement agent containing coral sand
Takeda et al. Effect of age and dietary protein level on tissue mineral levels in female rats
Schafer et al. Exposure, bioavailability, distribution and excretion of aluminum and its toxicological relevance to humans
Clarkson et al. Phosphate depletion and glucocorticoid-induced hyperphosphatemia in lymphoblastic leukemia
JP3918646B2 (ja) 金属含有アミンリン酸塩からなる重金属処理剤及びそれを用いた重金属の固定化処理方法
Clark et al. Prevention of phosphate-induced nephrocalcinosis by parathyroidectomy
EP0403244B1 (en) Water treatment process
Genter Magnesium, calcium, strontium, barium, and radium
Kallmeyer, JC, Seimon, LP & MacSearraigh The effect of thyrocalcitonin therapy and phosphate deprivation on tumoral calcinosis
Hardwick Dental caries and trace elements
Volf et al. Retention of Strontium 85 in Rats: II. Effect of various barium sulphate preparations as influenced by soluble sulphates, carrier strontium and by the physiologic state of animals
Spencer et al. Inhibition of radiostrontium absorption in man
DE174558C (zh)
DE19530882A1 (de) Arzneimittel zur Vorbeugung, Begleittherapie und Heilung von Geschwulstkrankheiten
Werner et al. Elektroneutrale Pb4O4-Heterokubaneinheiten in den Aluminatsodalithen Ln4 [Al12O24](Pb4O4) 2 (Ln= Nd, Sm)/Electrically Neutral Pb4O4 Heterocubane Units in Aluminate Sodalites Ln4 [Al12O24](Pb4O4) 2 (Ln= Nd, Sm)

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication